Health · Healthcare & Policy · 1 day ago
India proposes approval requirement for prescription drug ads by sellers
India’s health ministry has proposed extending prescription drug advertising rules to retailers, wholesalers and distributors.
The proposal covers medicines listed under Schedules H, H1 and X, which include some antibiotics and psychotropic drugs.
These medicines require medical supervision.
Under the existing framework, pharmaceutical manufacturers already need prior government approval to advertise them.
The proposed change would apply the same requirement to businesses licensed to sell or distribute the medicines.
The ministry’s proposal follows recommendations from the Drugs Technical Advisory Board.
It has not yet taken effect.
India’s Union health ministry has proposed requiring retailers, wholesalers and distributors to obtain central government approval before advertising medicines in Schedules H, H1 and X.
The proposal would add a new sub-rule under Rule 65 of the Drugs Rules, 1945, covering entities licensed to sell, stock, exhibit, offer for sale or distribute the medicines.
The Economic Times reports that the proposal follows recommendations from the Drugs Technical Advisory Board.
The medicines covered include prescription drugs such as certain antibiotics and psychotropic drugs, which require medical supervision.
The Times of India says existing rules already require prior government approval for advertisements of these medicines, while the Economic Times says that requirement currently applies to pharmaceutical manufacturers.
- Who
- India’s Union health ministry; retailers, wholesalers and distributors of the specified medicines
- What
- A proposal to require central government approval before these sellers and distributors advertise Schedule H, H1 and X medicines
- When
- Proposed on October 9, 2026
- Where
- India
- Why
- To extend existing advertising restrictions to entities involved in selling and distributing the medicines
This story does not have two clearly opposing sides.
No direct quotes in the coverage so far.
This story does not have a timeline yet.
- Proposed rule
- A new sub-rule under Rule 65 of the Drugs Rules, 1945
- Drug categories
- Schedules H, H1 and X
- Approval authority
- Central government
- Recommendation
- The Economic Times reports that the proposal followed recommendations from the Drugs Technical Advisory Board
Sources
Related news
Elder care managers help US families navigate care and paperwork
Brain stimulation centre opens at medical institute in Guntur
Medicine shortages reported at camps near Vijayawada’s Kanaka Durga temple
Moving a loved one into a care home can be hard on family caregivers
Luigi Carbone coordinates medical care for Pope Leo XIV
KPN outage disrupts phone access to several Dutch university hospitals
Humana gains in 2027 Medicare Advantage ratings as Alignment falls
India approves 30% trade-margin cap on non-scheduled cancer drugs
Hospitals sue to block revised federal 340B drug rebate plan
Medicaid cuts raise risk of more US maternity ward closures
Pope Leo XIV says he will have surgery for lung nodule
